Evidence map›Paper›PMID 31426477›Full record

ArticleMolecules (Basel, Switzerland)2019

Inhibitory Effects of Ginsenoside Ro on the Growth of B16F10 Melanoma via Its Metabolites.

Si-Wen Zheng, Sheng-Yuan Xiao, Jia Wang, Wei Hou, Ying-Ping Wang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Targeting Lysosomes for Enhanced Anti-Cancer Therapeutics and Immune Response.International journal of biological sciences · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Recent trends in ginseng research.Journal of natural medicines · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Diversity and Isolation of Endophytic Fungi inCurrent pharmaceutical biotechnology · 2024
    Article
  15. Therapeutic Applications of Ginseng Natural Compounds for Health Management.International journal of molecular sciences · 2023
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Si-Wen ZhengInstitute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun 130112, China.
Sheng-Yuan XiaoNational & Local Joint Engineering Research Center for Ginseng Breeding and Development, Changchun 130118, China.
Jia WangSchool of Pharmaceutical Sciences Changchun University of Chinese Medicine, Changchun 130117, China.
Wei HouInstitute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun 130112, China.
Ying-Ping WangInstitute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun 130112, China. yingpingw@126.com.
Institute of Special Animal and Plant Sciences · CNChangchun University of Chinese Medicine · CN

Funding

National Key R&D Program of China 2017YFC1702102Natural Science Foundation of Jilin Province 20170101011JC
6 · The paper itself

Abstract

Ginsenoside Ro (Ro), a major saponin derived and isolated from

Indexed as

Angiogenesis InhibitorsAnimalsAntineoplastic Agents, PhytogenicBiotransformationGinsenosidesHemolysisMelanocytesMelanoma, ExperimentalMiceMice, Inbred C57BLNeoplasm TransplantationOleanolic AcidPanaxPlant ExtractsSaponinsSkin NeoplasmsAngiogenesis InhibitorsAntineoplastic Agents, Phytogeniccalenduloside Echikusetsu saponin IVaginsenoside RoGinsenosidesOleanolic AcidPlant ExtractsSaponinsanti-tumourB16F10ginsenoside Rometabolites

Identifiers

PMID31426477
PMCPMC6721120
OpenAlexW2968882583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.